8-KThe WireRed Alert
Executive Change · Shareholder Vote
Filed Jun 22, 2026 · 11d ago · Accession 0001193125-26-276718
Plain English
Revolution Medicines, Inc. reported on June 18, 2026, that its president, research and development, Steve Kelsey, M.D., FRCP, FRCPath, intends to retire effective January 4, 2027, and that stockholders voted on three proposals at the annual meeting.
Filing details
- Company
- Revolution Medicines, Inc.
- Ticker
- RVMD
- CIK
- 1628171
- Form type
- 8-K
- Filing date
- Jun 22, 2026
- Report date
- Jun 18, 2026
- Document
- d123125d8k.htm
- Size
- 184 KB